COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Lungcast: Resilience and Sustainability: Preparing Healthcare for the Future with Elizabeth Cerceo, MD Albert Rizzo, MD, Elizabeth Cerceo, MD

This episode of Lungcast features a discussion on emerging treatment approaches for SCLC.

Long-Term Data Support New Zopapogene Imadenovec Approval for RRP Victoria Johnson

New long-term data reveals that Papzimeos offers sustained relief for adults with recurrent respiratory papillomatosis, reducing the need for surgeries.

Nerandomilast Approval Breaks Decade-Long Dry Spell for IPF, With Toby Maher, MD, PhD Toby Maher, MD, PhD

Maher discussed the new FDA approved drug, marketed as Jascayd, and its impact for idiopathic pulmonary fibrosis.

Mucoactives Found to Have Little Benefit for Bronchiectasis Victoria Johnson

A recent study reveals that hypertonic saline and carbocisteine do not effectively reduce pulmonary exacerbations.

FDA Accepts NDA for Chiesi’s Single Inhaler Triple Therapy for Asthma Victoria Johnson

The therapy is currently approved in almost 50 countries under the name Trimbow.

Todays Updates

Multi-Arm Phase 2 Trial Fails to Show Efficacy for Cognitive Programs in Treating Long COVID Marco Meglio

A recent trial reveals that online cognitive training and other interventions are ineffective for treating long COVID cognitive symptoms, highlighting treatment challenges.

Todays Updates

Multi-Arm Phase 2 Trial Fails to Show Efficacy for Cognitive Programs in Treating Long COVID Marco Meglio

A recent trial reveals that online cognitive training and other interventions are ineffective for treating long COVID cognitive symptoms, highlighting treatment challenges.

Latest News

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

This episode of Lungcast features a discussion on emerging treatment approaches for SCLC.

New long-term data reveals that Papzimeos offers sustained relief for adults with recurrent respiratory papillomatosis, reducing the need for surgeries.

Maher discussed the new FDA approved drug, marketed as Jascayd, and its impact for idiopathic pulmonary fibrosis.

A recent study reveals that hypertonic saline and carbocisteine do not effectively reduce pulmonary exacerbations.

The therapy is currently approved in almost 50 countries under the name Trimbow.

News All Time

Dupilumab Lessens COPD Exacerbation Impact, with Nicola Hanania, MD, MS Nicola Hanania, MD, MS

Hanania discusses the pooled BOREAS and NOTUS post hoc data showing dupilumab protects lung function before and after COPD exacerbations.

Extended-Release Nalbuphine Improves Patient-Reported Refractory Chronic Cough Within 1 Week Imran Satia, MD, PhD

Imran Satia, MD, PhD, discusses promising phase 2A trial data showing quick and significant improvements in patients' perception of cough frequency and severity.

Baseline Type 2 Biomarkers Can Predict Asthma Remission with Dupilumab, with Mario Castro, MD, MPH Kevin Kunzmann

Castro discusses new data from CHEST 2025 showing the value of baseline blood eosinophils and FeNO in understanding potential dupilumab outcomes.

Dry Powder Treprostinil Tolerated Among Patients with PH-ILD, with Nicholas Kolaitis, MD Kevin Kunzmann

Kolaitis discussed interim findings from the ASCENT trial, which showed ability to increase treprostinil dosing while maintaining a safe and efficacious profile.

Aroxybutynin and Atomoxetine (AD109) Reduces Obstructive Sleep Apnea Burden in Phase 3 SynAIRgy Kevin Kunzmann

Late-breaking data at CHEST 2025 support the novel combination therapy, which may be submitted to the FDA in application for patients with OSA in coming months.

From Slowing Decline to Restoring Function: Taladegib’s Promise in IPF, With Toby Maher, MD, PhD Toby Maher, MD, PhD

Maher discussed taladegib's potential to improve FVC, rather than slow decline, in people with idiopathic pulmonary fibrosis.

Dupilumab Reduces Mucus Burden in Uncontrolled Asthma, with Njira Lugogo, MD Njira Lugogo, MD

Mucus plugs are an increasingly present issue in uncontrolled asthma. Lugogo discusses promising findings from VESTIGE that addresses them.

Defining the Future of Asthma Remission, With Linda Rogers, MD

Defining the Future of Asthma Remission, With Linda Rogers, MD

Dupilumab Bests Omalizumab in Airway Improvement for Patients with CRSwNP and Asthma Kevin Kunzmann

Data from the phase 4 head-to-head EVEREST trial further indicates dupilumab's benefit for type 2 inflammatory airway disease.

The Asthma and COPD Precision Medicine Era, with Nicola A. Hanania, MD, MS

The Asthma and COPD Precision Medicine Era, with Nicola A. Hanania, MD, MS

Personalized COPD Treatment: Lessons from Biologic Trials and Clinical Practice

Personalized COPD Treatment: Lessons from Biologic Trials and Clinical Practice

Early morning practices linked to less and lower-quality sleep in college athletes

A study using more than 27,000 sleep records of collegiate athletes provides the best evidence to date that early morning team practices take a toll on healthy sleep.

Dreaming of fewer running injuries? Start with better sleep

If you are among the 620 million people who lace up their running shoes on a regular basis, chances are that you're an early riser.

Daylight robbery? How London's skyscrapers deprive marginalized people of light

When you look at the promotional materials advertising luxury high-rise developments in London, it is obvious that the fantasy of living in the sky is fused by a desire for sunlight and "unobstructed" views of the city. Phrases ...

Chronic fatigue syndrome linked to high rates of dysfunctional breathing patterns

Chronic fatigue syndrome leaves patients exhausted and struggling with brain fog—and it typically gets worse after mental or physical exercise, a phenomenon called post-exertional malaise.

Moderate to severe sleep apnea tied to higher risk of brain microbleeds

Research led by Korea University Ansan Hospital reports finding an association between moderate to severe obstructive sleep apnea and increased risk of cerebral microbleeds.

Recommended News For You

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

Taking Charge of Your Cancer Journey.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.

Basal stem-like cells identified as origin of small cell lung cancer in lab models

Recommended Articles For You

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management 

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide  

Everything You Need to Know About the Latest Hyponatremia Algorithm  

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Effects of Recombinant Replacement Therapy Explained in Detailed Regarding Genetic Clotting Disorder.

2.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

3.

Breast cancer-related fatigue: The benefits of adapted physical activity

4.

Study finds 81% of cancer cures touted by TikTok videos are fake

5.

Women who miss their first mammogram face higher risk of breast cancer death, study finds

1.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

2.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

3.

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis

4.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

5.

Exploring the Normal Range of Monocytes: A Comprehensive Guide

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

2.

Navigating the Complexities of Ph Negative ALL - Part IV

3.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot